Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00063089 |
|
Recruitment Status
:
Completed
First Posted
: June 20, 2003
Last Update Posted
: May 14, 2012
|
Sponsor:
Nabi Biopharmaceuticals
Information provided by (Responsible Party):
Nabi Biopharmaceuticals
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | September 2004 |
| Actual Study Completion Date : | September 2004 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):